← Back to Search

Mind-Body Medicine for Lymphoma

N/A
Waitlist Available
Led By Kathrin Milbury
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying how well a meditation-based mind-body intervention can improve quality of life for adolescents and young adults with lymphoma.

Who is the study for?
This trial is for young adults aged 18-39 recently diagnosed with any stage of Lymphoma. They should be relatively active (ECOG status 2 or below), have internet access, and be fluent in English. It's not suitable for those with major psychiatric issues or who are already in regular psychotherapy or cancer support groups.
What is being tested?
The study tests a mind-body intervention that includes educational materials, meditation therapy, and questionnaires to see if it improves life quality by reducing distress, depression, and anxiety among young lymphoma patients.
What are the potential side effects?
Since the interventions involve non-invasive practices like education and meditation therapy rather than medication, significant physical side effects are not expected; however emotional discomfort could arise when addressing illness-related topics.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mind-body intervention in (AYAs) Adolescents and Young Adults with Lymphoma Questionnaire
Secondary study objectives
Psychological distress and cancer symptoms (tertiary objective) relative to an attention control (AC) group Questionnaire

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (meditation)Experimental Treatment2 Interventions
Patients attend meditation group sessions over 75 minutes once weekly for up to 5 weeks.
Group II: Group II (educational)Active Control2 Interventions
Patients attend educational group sessions over 75 minutes once weekly for up to 5 weeks.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,907 Previous Clinical Trials
41,012,073 Total Patients Enrolled
1,405 Trials studying Lymphoma
382,873 Patients Enrolled for Lymphoma
M.D. Anderson Cancer CenterLead Sponsor
3,063 Previous Clinical Trials
1,800,710 Total Patients Enrolled
259 Trials studying Lymphoma
32,473 Patients Enrolled for Lymphoma
Kathrin MilburyPrincipal InvestigatorM.D. Anderson Cancer Center
7 Previous Clinical Trials
1,880 Total Patients Enrolled
~20 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top